<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In this report we describe the clinical and hematologic features of 23 cases of <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) or <z:hpo ids='HP_0011009'>acute</z:hpo> megakaryoblastic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (AMKL) occurring in <z:e sem="disease" ids="C0013080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Down's syndrome</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> was characterized by <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>, abnormal megakaryocytopoiesis, megakaryoblasts (&lt; 30%) in the marrow and abnormal karyotype, the most common of which was <z:mp ids='MP_0004027'>trisomy</z:mp> 8, found in 7/15 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Three of five patients achieved a complete remission with low dose <z:chebi fb="1" ids="16040">cytosine</z:chebi> <z:chebi fb="0" ids="22601">arabinoside</z:chebi>, <z:chebi fb="0" ids="28445">vincristine</z:chebi> and <z:chebi fb="0" ids="15040">retinyl palmitate</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>The high cure rate and the distinctive features of the leukemic process in these cases suggest that this type of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and AMKL are unique to patients with <z:e sem="disease" ids="C0013080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Down's syndrome</z:e> </plain></SENT>
</text></document>